MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $65,260,966 | +639.8% | 2,420,659 | +392.8% | 0.02% | +650.0% |
| Q3 2022 | $8,821,000 | +69.6% | 491,162 | +17.4% | 0.00% | +100.0% |
| Q2 2022 | $5,200,000 | +85.4% | 418,336 | +98.7% | 0.00% | 0.0% |
| Q1 2022 | $2,804,000 | -4.9% | 210,509 | +11.1% | 0.00% | 0.0% |
| Q4 2021 | $2,950,000 | +1.8% | 189,490 | +46.7% | 0.00% | 0.0% |
| Q3 2021 | $2,898,000 | -28.8% | 129,151 | -27.7% | 0.00% | 0.0% |
| Q2 2021 | $4,070,000 | -48.4% | 178,745 | -53.3% | 0.00% | -50.0% |
| Q1 2021 | $7,884,000 | +113.4% | 383,087 | +186.4% | 0.00% | +100.0% |
| Q4 2020 | $3,695,000 | +51.6% | 133,774 | -22.9% | 0.00% | 0.0% |
| Q3 2020 | $2,438,000 | +39.2% | 173,514 | +104.3% | 0.00% | 0.0% |
| Q2 2020 | $1,751,000 | +252.3% | 84,938 | +29.1% | 0.00% | – |
| Q1 2020 | $497,000 | -39.0% | 65,781 | +25.3% | 0.00% | – |
| Q4 2019 | $815,000 | +242.4% | 52,516 | +14.6% | 0.00% | – |
| Q3 2019 | $238,000 | +39.2% | 45,812 | +143.1% | 0.00% | – |
| Q2 2019 | $171,000 | -14.9% | 18,845 | +99.5% | 0.00% | – |
| Q1 2018 | $201,000 | +15.5% | 9,444 | -36.4% | 0.00% | – |
| Q2 2017 | $174,000 | -97.0% | 14,853 | -96.8% | 0.00% | -100.0% |
| Q4 2016 | $5,780,000 | – | 464,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |